Checkpoint therapy in cancer treatment: progress, challenges, and future directions.

The article focuses on the advancements and challenges of immune checkpoint blockade (ICB) therapy in cancer treatment. Topics include the historical context and development of ICB, mechanisms of action and resistance, and the exploration of biomarkers and combination therapies to enhance efficacy and overcome treatment limitations.